News

ProPhase Labs Unveils Revolutionary Findings in Esophageal Cancer Research

ProPhase Labs Unveils Revolutionary Findings in Esophageal Cancer Research

ProPhase Labs Announces Significant Advances in Esophageal Cancer Detection

Innovative Collaborations Redefine Risk Stratification for Esophageal Cancer Patients

UNIONDALE, NY — ProPhase Labs, Inc. (NASDAQ: PRPH) has made headlines with the publication of a pivotal study titled, “Assessing Risk of Progression in Barrett’s Esophagus Using a Mass-Spectrometry-Based Proteomic Panel,” featured in the respected journal, Clinical and Translational Gastroenterology — the official journal of the American College of Gastroenterology (ACG).

Understanding the BE-Smart Assay

The recently published study presents groundbreaking clinical validation data that supports the BE-Smart assay, an innovative 8-protein mass-spectrometry-based tool designed for identifying patients with Barrett’s Esophagus (BE) who are likely to progress toward more severe conditions, such as high-grade dysplasia or esophageal adenocarcinoma. Partnering with the renowned Mayo Clinic, this research stands out for its insightful results that could transform how gastroenterologists approach cancer risks in their patients.

Key Findings from the Study

Several noteworthy findings emerged from the study, highlighting BE-Smart’s effectiveness. First and foremost, the assay achieved an impressive 100% sensitivity for detecting patients who eventually developed esophageal adenocarcinoma. This means that every patient in the study who progressed to cancer was accurately identified, showcasing the test’s reliability and potential for real-world application.

Further analysis revealed a robust predictive performance, substantiated by an area under the curve (AUC) of 0.75 across various assessments, with a remarkable AUC of 0.89 in an independent cohort. For patients at risk of progressing in a three-year timeframe, BE-Smart achieved a flawless AUC of 1.0, effectively identifying all individuals who faced advanced disease developments.

Additionally, the study reported a significant hazard ratio of 66.1, indicating that those classified as high-risk by BE-Smart are approximately 66 times more prone to progress to esophageal cancer compared to their low-risk counterparts. This correlation illustrates BE-Smart's robust predictive capabilities and its alignment with clinical outcomes.

Transforming Traditional Assessments

BE-Smart's approach marks a departure from traditional tissue-based assays, which often require larger biopsy samples. This new assay can derive comprehensive molecular profiles from just a small amount of tissue, significantly enhancing its applicability in clinical settings. BE-Smart can utilize samples from both forceps and brush biopsies, integrating seamlessly into existing gastroenterology workflows.

The Future of Esophageal Cancer Detection

Ted Karkus, CEO of ProPhase Labs, remarked on the study’s significance: “The publication in a leading journal showcases BE-Smart’s scientific rigor and clinical implications.” The transition toward molecular-level assessment in gastroenterology signifies a more refined, cost-effective method that promises better patient outcomes.

Dr. Joe Abdo, ProPhase Labs’ Scientific Advisor, emphasized the tech’s innovation, noting, “With BE-Smart, a microscope isn't even needed. Our high-fidelity mass spectrometry identifies and quantifies numerous biomarkers quickly from a single tissue slice, paving the way for advanced detection methods.”

ProPhase's Commitment to Innovation

ProPhase Labs is diligently working towards the commercialization of BE-Smart, prioritizing laboratory partnerships and payer engagements, while planning to launch early access programs by 2026. As they propel this technology into the healthcare landscape, the objective remains clear: to enhance early detection methods, ultimately saving lives.

With over twenty thousand Americans diagnosed with esophageal cancer each year, tools like BE-Smart are crucial in identifying at-risk individuals sooner, thereby boosting the chances for effective treatment and positive outcomes.

About ProPhase Labs

ProPhase Labs Inc. (NASDAQ: PRPH) stands at the forefront of biotechnology and consumer health innovations. Committed to delivering actionable health insights, the company is advancing its position in the healthcare sector with new technologies, including whole genome sequencing solutions and groundbreaking diagnostic products aimed at transformative patient care.

For further information, interested parties can reach out via investor relations contact at investorrelations@prophaselabs.com or explore more details at ProPhase's website.

Frequently Asked Questions

What is the BE-Smart assay?

The BE-Smart assay is a mass-spectrometry-based proteomic test designed to identify Barrett’s Esophagus patients at risk of progressing to esophageal cancer.

How effective is the BE-Smart assay?

The assay demonstrated 100% sensitivity in identifying patients who progressed to esophageal adenocarcinoma, making it a reliable tool for early detection.

Where has the BE-Smart study been published?

The findings were published in the journal, Clinical and Translational Gastroenterology, which is associated with the American College of Gastroenterology.

What distinguishes BE-Smart from traditional tests?

Unlike traditional tests that require larger tissue samples, BE-Smart uses minimal tissue for comprehensive molecular profiling, making it more efficient for clinical use.

How is ProPhase Labs advancing BE-Smart’s commercial availability?

The company is focused on securing laboratory partnerships and engaging with payers, with an aim to begin early access programs by 2026.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Makers Nutrition Credit Puts a Clock on New Brands

Updated Category News Views 163

A few cents per bottle can look downright beautiful when a new supplement brand is staring at its first production bill. Makers Nutrition announced on November 17 a Black Friday manufacturing-credit offer aimed at entrepreneurs and established sellers launching a new formulation, with qualifying new orders eligible for as much as $0.45 per unit through November 29, 2026....

Continue Reading
SanMar’s Lott Tops Promo Products Power 50 Again in 2026

Updated Category News Views 89

Branded hoodies and logo tumblers rarely make Wall Street’s pulse race, but the numbers behind them deserve a hard look. Jeremy Lott, president and CEO of SanMar, was named the most influential leader in the U.S. promotional-products business for the second consecutive year, taking No. 1 in the 2026 Counselor Power 50 ranking. Awards can be fluff. A repeat win beside...

Continue Reading
Elisity’s Texas Water Pilot Puts IonQ’s Deal in View

Updated Category News Views 129

Water-system security is not a place for chest-thumping Elisity’s role in Texas Project Watershed 250 lands on a problem that is painfully concrete: water and wastewater utilities have to keep pumps, treatment systems and plant operations running while trying to close cybersecurity gaps. That is a tougher job than selling another dashboard to a corporate IT department....

Continue Reading
Docusign Pushes Contract Data Into ChatGPT Sales Tools

Updated Category News Views 120

Contracts are where sales momentum goes to get lost, buried under old PDFs, approval chains, and somebody’s half-finished CRM note. Docusign’s November 17, 2026 launch is a sensible attempt to drag that information into the place sellers may increasingly spend their working day: ChatGPT for Sales. The company’s new plugin lets a sales rep pull agreement intelligence...

Continue Reading
Envision and Tai Tam Put 45 MW Wind Bet to Work in Vietnam

Updated Category News Views 25

A wind site averaging 6.5 meters per second can look unremarkable on a map, yet that is precisely where equipment choices start separating serious developers from brochure merchants. Envision Energy and Vietnam's Tai Tam Group are taking that test on with the 45 MW Phuoc Dan wind project in Khanh Hoa Province. The arrangement follows five years of cooperation, but the...

Continue Reading
DEFSEC Tackles Nasdaq Bid Price Hurdle with Share Move

Updated Category News Views 25

Navigating Bid Price Deficiency Issues Well, it seems DEFSEC Technologies Inc. found themselves in a tricky spot last week. A nasty gram from Nasdaq’s Listing Qualifications Department pointing out that DEFSEC's shares had dipped below that $1.00 per share requirement for too long—a full 30 business days. Now, don't panic just yet. This isn't about the shares getting...

Continue Reading
TYYY Liquidation Leaves Holders With a Tight Exit Window

Updated Category News Views 144

A fund can vanish faster than investors can read the fine print, and TYYY is doing exactly that. Exchange Traded Concepts has approved the closure and liquidation of the xETFs TSLA Daily Income ETF, with the fund expected to cease operations and distribute cash on or about November 20, 2026. This is not a debate about whether holders should love or hate Tesla. The product...

Continue Reading
Iberostar's Grand Move: Opening in Zanzibar

Updated Category News Views 74

The Resort That Takes Your Breath Away Here we have Iberostar, boldly wading into the azure waters of the Indian Ocean, planting its flag on the sandy beaches of Zanzibar. This isn’t just another notch on the resort’s belt—it’s their first time setting up shop in East Africa, a move ripe with promise and adventure both. A Suite So Sweet 358 suites, mind you. Each...

Continue Reading
Inhibrx Ewing Data Gives Ozekibart a Real Clinical Signal

Updated Category News Views 84

Numbers this lopsided in relapsed Ewing sarcoma make me sit up straight, even after years of watching oncology releases try to turn every blip into a brass band. Inhibrx has reported updated Phase 1/2 data for ozekibart, paired with irinotecan and temozolomide, that look genuinely notable in a disease where patients have very few good cards left to play. That matters...

Continue Reading
Bona's 2027 Floorcast Finds Wood and Trust Still Win

Updated Category News Views 147

Floors are turning into a long-game purchase again Gray flooring may be limping toward the exit, but the more important signal in Bona's 2027 Floorcast is that homeowners are thinking less like bargain hunters and more like custodians of an expensive asset. That is a useful read for anybody watching the home-improvement and maintenance landscape. People do not replace a...

Continue Reading

Top 5 Most Recently Viewed Articles

Joseph Margolis Shows Strong Faith in Extra Space Storage

Updated Category News Views 133

Joseph Margolis Shows Strong Faith in Extra Space Storage Recently, a significant insider purchase was conducted by Joseph Margolis, who holds the position of Chief Executive Officer at Extra Space Storage (EXR). According to the latest SEC filing, Margolis acquired 27,741 shares of the company, amounting to a considerable investment of $4,232,166. The market had a...

Continue Reading
Investigation Into Arcadium Lithium Sale Sparks Concerns

Updated Category News Views 192

Investigation Launched into Arcadium Lithium Shareholder Rights The former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., is leading an inquiry regarding an important corporate transaction involving Arcadium Lithium plc (NYSE: ALTM). This investigation, undertaken by the law firm Kahn Swick & Foti, LLC, seeks to assess whether the terms of the proposed sale to...

Continue Reading
Actian Introduces Advanced Federated Data Catalog for Businesses

Updated Category News Views 148

Actian Launches Innovative Federated Data Catalog Actian, the data and analytics division of HCLSoftware, is setting new standards in data management with the introduction of the Actian Zeenea Federated Data Catalog. This advanced platform simplifies data discovery, empowering users across enterprises to harness valuable data resources effectively. With the acquisition of...

Continue Reading
Oil-Dri Corporation Reports Impressive Second Quarter Growth

Updated Category News Views 123

Oil-Dri Corporation Achieves Significant Growth Oil-Dri Corporation of America (NYSE: ODC), a reputable name in the production and marketing of sorbent mineral products, has shared its impressive financial performance for the second quarter of fiscal 2025, marking substantial growth for the company. Financial Highlights of the Second Quarter During this reporting period,...

Continue Reading
Power Metallic: Drill Assays Fuel Growth Optimism at Lion

Updated Category News Views 34

Striking Copper: Panning Out or Fools' Gold? Well, here's a dose of copper digging straight from the heart of the Lion Zone with Power Metallic Mines (TSXV: PNPN, OTCBB: PNPNF) at the helm. Now, if copper's your game, the latest assay results might just tickle your fancy. We're talking hefty 13.30 meters at 3.98% CuEqRec in hole 26-115 and, get this, a juicy 5.26 meters...

Continue Reading